Skip to content
ESPT
MARKETS / Health care / Medical devices and instruments / AVNS
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP

Avanos Medical, Inc. AVNS

14 fiscal years on record · USD · FY2025 reported · SEC filings only
$701.2M
▲ 1.9% YoY
$-72.9M
$43.1M
▼ 48.0% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

It develops, manufactures and markets medical device products globally. It has more than 2,200 employees. It has manufacturing facilities in the United States, Mexico and Canada. It conducts its business in two operating and reportable segments, Specialty Nutrition Systems and Pain Management and Recovery, that provide its medical device products to healthcare providers and patients. Its Specialty Nutrition Systems segment includes enteral feeding products such as its MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, each of which individually accounted for more than 10% of its consolidated net sales in the years ended December 31, 2025, 2024 and 2023. Its Pain Management and Recovery segment offers non-opioid pain solutions, including surgical pain and recovery products such as its ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. It was originally incorporated in Delaware in 2014.

Written from the business description in Avanos Medical, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.

Growth

USD 701.2M
Revenue, FY2025 · full 14-year series below
Revenue $B Net income $B
FY2025 · Revenue 0.7 · Net income -0.1
1.0B2.0B-0.1B-0.3B
201220152018202120242025
Compound annual growth
+0.8%
−0.4%
+3.3%
−61.0%
+23.6%
+10.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −0.4% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−10 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -8.8% · Net -10.4%
5%10%-50%
201220182025
ROE
FY2025 · ROE -9.1%
2%4%6%-10%-20%-30%
201220182025
Three returns, three denominators.
Gross margin50.5%
Operating margin-8.8%
Net margin-10.4%
EBITDAUSD -22.7M

Each USD of equity lost 9 cents this year.

Cash & shareholders

USD 2.6M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 43.1
100M200M-100M-200M
201220182025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 2.6
20M40M
2013201520172019202120232025
Dividends paid·
Net buybacksUSD 2.6M
Share of profit-3.6%
Consecutive raises·

USD 2.6M in buybacks went back to shareholders in a year without profit.

Total assetsUSD 1.1B
EquityUSD 778.2M
CashUSD 89.8M
Gross debtUSD 100.5M
Net debtUSD 10.7M
Current ratio2.15×

Net debt stands at 1% of equity.

The 14-year record

14 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
AVNS, 14-year financial record
Metric 20252024202320222021202020192018201720162015201420132012
Revenue $B0.70.70.70.70.60.70.70.70.60.60.51.71.71.7
Operating income $B−0.1−0.40.00.0−0.0−0.0−0.10.0−0.0−0.1−0.10.10.20.2
EBITDA $B−0.0−0.40.10.1−0.0−0.0−0.00.00.0−0.0−0.10.20.30.3
Income tax $B0.0−0.00.00.0−0.0−0.0−0.0−0.0−0.0−0.1−0.10.10.10.1
Net income $B−0.1−0.4−0.10.10.0−0.0−0.00.10.10.0−0.40.00.20.2
Free cash flow $B0.00.10.00.10.1−0.0−0.1−0.20.10.20.00.10.20.2
EPS, diluted $−1.57−8.53−1.321.070.13−0.61−0.961.221.690.85−9.150.583.323.28
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout %———————0——————
ROE %−9.1−38.0−4.93.90.5−2.3−3.64.66.83.7−33.51.57.57.4
Shares out B0.050.050.050.050.050.050.050.050.050.050.050.05◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

MCK · COR · CAH · JNJ · HCA · LLY
Provenance

Company facts, as filed

How we verify · 0 failures in 67 reconciliationsAUDITED

Reconciled in 14 of the 14 fiscal years we could check. 12 checks were skipped: the balance sheet is not tagged before 2013. Six checks were skipped: the share count is not tagged before 2013. Five checks were skipped: revenue is not tagged before 2012.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onnot stated in the filings
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2012

Share this section

Download image